A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo

BACKGROUND: Cases of higher-than-expected disease activity have been reported following fingolimod discontinuation. OBJECTIVE: The objective of this paper is to assess the risk of substantially higher-than-expected disease activity post-study drug discontinuation (SDD) at the individual patient leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermersch, Patrick, Radue, Ernst-Wilhelm, Putzki, Norman, Ritter, Shannon, Merschhemke, Martin, Freedman, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624444/
https://www.ncbi.nlm.nih.gov/pubmed/28989795
http://dx.doi.org/10.1177/2055217317730096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624444/
https://www.ncbi.nlm.nih.gov/pubmed/28989795
http://dx.doi.org/10.1177/2055217317730096

Ejemplares similares